Histopathological evaluation in post-mortem renal biopsies of patients with COVID-19 and comorbidities: a case-control study.

IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Sao Paulo Medical Journal Pub Date : 2026-01-19 eCollection Date: 2026-01-01 DOI:10.1590/1516-3180.2024.0376.R1.13102025
Samya Hamad Mehanna, Mayara Pezzini Arantes, Henrique Machado de Souza Proença, Rafael Weissheimer, Sérgio Ossamu Ioshii, Micheli Ito Gimenes Pires, Julia Wolf Barretto, Eduardo Morais de Castro, Thyago Proença de Moraes, Lucia de Noronha
{"title":"Histopathological evaluation in post-mortem renal biopsies of patients with COVID-19 and comorbidities: a case-control study.","authors":"Samya Hamad Mehanna, Mayara Pezzini Arantes, Henrique Machado de Souza Proença, Rafael Weissheimer, Sérgio Ossamu Ioshii, Micheli Ito Gimenes Pires, Julia Wolf Barretto, Eduardo Morais de Castro, Thyago Proença de Moraes, Lucia de Noronha","doi":"10.1590/1516-3180.2024.0376.R1.13102025","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute kidney injury is one of the main systemic complications of severe coronavirus disease 2019 (COVID-19).</p><p><strong>Objectives: </strong>To examine histopathological changes in post-mortem kidney biopsies of patients who died as a result of the disease caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).</p><p><strong>Design and setting: </strong>A case-control study was conducted at a tertiary hospital located in Curitiba, Paraná, Brazil.</p><p><strong>Methods: </strong>The study group, called \"COVID,\" consisted of kidney biopsy samples obtained from deceased patients with COVID-19, with a \"Control\" group included for comparison. Samples were selected based on sex, age, and comorbidities, with an emphasis on diabetes mellitus and systemic arterial hypertension (SAH). Morphological evaluation was performed by pathologists using preestablished criteria with glomerular, tubular, and vascular characteristics among the parameters.</p><p><strong>Results: </strong>Tubular atrophy and interstitial fibrosis, markers of chronic kidney injury, were observed with equal frequency in both groups, probably because of the initial pairing of the samples. These findings are in line with what would be expected from chronic exposure to proteinuria. In relation to SAH, the main identification was interstitial vascular damage, particularly arteriolosclerosis/arteriosclerosis. Acute tubular injury was the most frequently observed feature in patients in the COVID group, which was probably related to ischemic damage.</p><p><strong>Conclusion: </strong>This study demonstrated that the main change identified in the renal parenchyma of patients with COVID-19 was acute tubular injury, which was expected considering the context of severe systemic ischemia to which these patients are subjected, with the other findings being the consequences of chronic damage.</p>","PeriodicalId":49574,"journal":{"name":"Sao Paulo Medical Journal","volume":"144 1","pages":"e2024376"},"PeriodicalIF":1.6000,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12834467/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sao Paulo Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/1516-3180.2024.0376.R1.13102025","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acute kidney injury is one of the main systemic complications of severe coronavirus disease 2019 (COVID-19).

Objectives: To examine histopathological changes in post-mortem kidney biopsies of patients who died as a result of the disease caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).

Design and setting: A case-control study was conducted at a tertiary hospital located in Curitiba, Paraná, Brazil.

Methods: The study group, called "COVID," consisted of kidney biopsy samples obtained from deceased patients with COVID-19, with a "Control" group included for comparison. Samples were selected based on sex, age, and comorbidities, with an emphasis on diabetes mellitus and systemic arterial hypertension (SAH). Morphological evaluation was performed by pathologists using preestablished criteria with glomerular, tubular, and vascular characteristics among the parameters.

Results: Tubular atrophy and interstitial fibrosis, markers of chronic kidney injury, were observed with equal frequency in both groups, probably because of the initial pairing of the samples. These findings are in line with what would be expected from chronic exposure to proteinuria. In relation to SAH, the main identification was interstitial vascular damage, particularly arteriolosclerosis/arteriosclerosis. Acute tubular injury was the most frequently observed feature in patients in the COVID group, which was probably related to ischemic damage.

Conclusion: This study demonstrated that the main change identified in the renal parenchyma of patients with COVID-19 was acute tubular injury, which was expected considering the context of severe systemic ischemia to which these patients are subjected, with the other findings being the consequences of chronic damage.

Abstract Image

Abstract Image

COVID-19患者死后肾活检的组织病理学评估及合并症:一项病例对照研究
背景:急性肾损伤是重症冠状病毒病2019 (COVID-19)的主要全身并发症之一。目的:探讨SARS-CoV-2(严重急性呼吸综合征冠状病毒2)所致死亡患者死后肾活检的组织病理学变化。设计和环境:在巴西帕拉纳岛库里蒂巴的一家三级医院进行了一项病例对照研究。方法:研究组被称为“COVID”,由已故COVID-19患者的肾活检样本组成,并包括一个“对照组”进行比较。样本的选择基于性别、年龄和合并症,重点是糖尿病和全身性动脉高血压(SAH)。病理学家使用预先建立的标准进行形态学评估,其中包括肾小球、肾小管和血管的特征。结果:两组慢性肾损伤的标志物肾小管萎缩和间质纤维化出现的频率相同,这可能与最初配对的样本有关。这些发现与长期暴露于蛋白尿的预期一致。关于SAH,主要鉴定是间质性血管损伤,特别是小动脉硬化/动脉硬化。急性肾小管损伤是COVID组患者最常见的特征,可能与缺血性损伤有关。结论:本研究表明,COVID-19患者肾实质的主要变化是急性肾小管损伤,考虑到这些患者遭受严重的全身缺血,这是意料之中的,其他结果是慢性损伤的后果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Sao Paulo Medical Journal
Sao Paulo Medical Journal 医学-医学:内科
CiteScore
2.20
自引率
7.10%
发文量
210
审稿时长
6-12 weeks
期刊介绍: Published bimonthly by the Associação Paulista de Medicina, the journal accepts articles in the fields of clinical health science (internal medicine, gynecology and obstetrics, mental health, surgery, pediatrics and public health). Articles will be accepted in the form of original articles (clinical trials, cohort, case-control, prevalence, incidence, accuracy and cost-effectiveness studies and systematic reviews with or without meta-analysis), narrative reviews of the literature, case reports, short communications and letters to the editor. Papers with a commercial objective will not be accepted.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书